Trade MDGL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Madrigal Pharmaceuticals, Inc. (MDGL) is trading at US$425.21, down 1.81% today as of Nov 12, 16:00 EST. The company has a market capitalisation of US$11.94B. Over the past 52 weeks, MDGL has traded between US$353.54 and US$615.00. On Syfe you can trade MDGL with $0 commission and add it to your watchlist.
| Previous close | US$433.03 |
|---|---|
| Market cap | US$11.94B |
| P/E ratio | 73.18 |
| 52-week range | US$353.54 – US$615.00 |
| Volume | 391.32K |
| Exchange | US |
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.
Year: 2007
Madrigal Pharmaceuticals, Inc. (MDGL) stock is trading at US$425.21, -1.81% from the previous close of US$433.03.
The market cap for Madrigal Pharmaceuticals, Inc. (MDGL) stock is approximately US$11.94B.
The price-to-earnings ratio for Madrigal Pharmaceuticals, Inc. (MDGL) is 73.18, based on the latest reported earnings.
The 52-week high for Madrigal Pharmaceuticals, Inc. (MDGL) stock is US$615.00.
The 52-week low for Madrigal Pharmaceuticals, Inc. (MDGL) stock is US$353.54.
Madrigal Pharmaceuticals, Inc. (MDGL) does not currently pay a dividend.
Stay on top of MDGL
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
